Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD32+CD4+ T Cells Sharing B Cell Properties Increase With Simian Immunodeficiency Virus Replication in Lymphoid Tissues. | Front Immunol | 2021 | 34220857 | PubTator, text mining | PubMed |
| Glycosylation of IgG Associates with Hypertension and Type 2 Diabetes Mellitus Comorbidity in the Chinese Muslim Ethnic Minorities and the Han Chinese. | J Pers Med | 2021 | 34209622 | PubTator, text mining | PubMed |
| Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies. | Cancers (Basel) | 2021 | 34208287 | PubTator, text mining | PubMed |
| Hymenoptera Venom Immunotherapy: Immune Mechanisms of Induced Protection and Tolerance. | Cells | 2021 | 34206562 | PubTator, text mining | PubMed |
| Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2021 | 34205588 | PubTator, text mining | PubMed |
| On the Use of Surface Plasmon Resonance Biosensing to Understand IgG-FcγR Interactions. | Int J Mol Sci | 2021 | 34205578 | PubTator, text mining | PubMed |
| Characterization of Rheumatoid Arthritis Risk-Associated SNPs and Identification of Novel Therapeutic Sites Using an In-Silico Approach. | Biology (Basel) | 2021 | 34199962 | PubTator, text mining | PubMed |
| Neutrophils and Influenza: A Thin Line between Helpful and Harmful. | Vaccines (Basel) | 2021 | 34199803 | PubTator, text mining | PubMed |
| Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach. | Int J Mol Sci | 2021 | 34199099 | PubTator, text mining | PubMed |
| Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels. | Clin Exp Allergy | 2021 | 34192382 | PubTator, text mining | PubMed |
| Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially regulates their synergistic and inhibitory receptor crosstalk. | Sci Rep | 2021 | 34183758 | PubTator, text mining | PubMed |
| Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI. | Front Immunol | 2021 | 34177967 | PubTator, text mining | PubMed |
| Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. | Front Immunol | 2021 | 34177935 | PubTator, text mining | PubMed |
| The Multiple Roles of B Cells in the Pathogenesis of Sjögren's Syndrome. | Front Immunol | 2021 | 34168653 | PubTator, text mining | PubMed |
| Gene Expression Profiling of Lymph Node Sub-Capsular Sinus Macrophages in Cancer. | Front Immunol | 2021 | 34168645 | PubTator, text mining | PubMed |
| Identification, characterization and control of a sequence variant in monoclonal antibody drug product: a case study. | Sci Rep | 2021 | 34168178 | PubTator, text mining | PubMed |
| B Cell Orchestration of Anti-tumor Immune Responses: A Matter of Cell Localization and Communication. | Front Cell Dev Biol | 2021 | 34164398 | PubTator, text mining | PubMed |
| Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab. | Asia Pac J Oncol Nurs | 2021 | 34159226 | PubTator, text mining | PubMed |
| Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia. | Sci Rep | 2021 | 34155276 | PubTator, text mining | PubMed |
| Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma. | Mol Ther Oncolytics | 2021 | 34141867 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=66